Related Experiment Videos

Cardiac involvement in beta-thalassemia/hemoglobin E disease: clinical and hemodynamic findings

P Jootar1, S Fucharoen

  • 1Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University.

Insights

Beta-thalassemia/hemoglobin E disease commonly causes right heart failure due to pulmonary hypertension. This study highlights the critical need for early detection and management of cardiac complications in these patients.

Area of Science:

  • Cardiology
  • Hematology
  • Pulmonology

Background:

  • Beta-thalassemia/hemoglobin E disease is a complex genetic blood disorder.
  • Cardiac complications, particularly right heart involvement, are increasingly recognized.
  • Previous research has not fully elucidated the spectrum of cardiac abnormalities in this population.

Purpose of the Study:

  • To investigate the clinical and hemodynamic manifestations of cardiac involvement in patients with beta-thalassemia/hemoglobin E disease.
  • To assess the prevalence and severity of right heart abnormalities and pulmonary hypertension.
  • To identify potential risk factors and clinical outcomes associated with cardiac dysfunction.

Main Methods:

  • Conducted clinical and hemodynamic evaluations in 8 patients (6 women, 2 men) with beta-thalassemia/hemoglobin E disease.
  • Utilized electrocardiography (ECG), echocardiography, and cardiac catheterization.
  • Assessed systemic blood pressure, heart rhythm, atrial size, repolarization, right heart function, pericardial effusion, and hypoxemia.

Main Results:

  • All patients presented with congestive heart failure; most had undergone splenectomy.
  • ECG showed normal sinus rhythm, right axis deviation, right atrial enlargement, and repolarization abnormalities.
  • Echocardiography detected right heart abnormalities and pericardial effusion; cardiac catheterization revealed hypoxemia and pulmonary hypertension in most patients.
  • Left ventricular dysfunction was observed in some individuals.

Conclusions:

  • Right heart involvement secondary to diffuse pulmonary thromboembolic disease is a major complication of beta-thalassemia/hemoglobin E disease.
  • Pulmonary hypertension and subsequent right heart failure are significant concerns.
  • Early cardiac screening and management are crucial for improving outcomes in patients with this condition.

Related Concept Videos